U.S. Markets open in 6 hrs, 56 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,005.96 | 203.82 | 2.08% |
| NASDAQ | 2,105.32 | 49.80 | 2.42% |
| S&P 500 | 1,066.63 | 20.13 | 1.92% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 26.17 09:43 AM EST | |
|---|---|---|
| Day High | 26.63 03:53 PM EST |
|
| Range | 0.46 |
| Volume | 1.01 M | |
|---|---|---|
| 30-Day Avg Vol | 1.72 M |
|
| Difference | -40.91% |
| Market Cap | 1.51 B | |
|---|---|---|
| Mkt Cap Chg | 10.85 M |
| Shares Out | 57.11 M | |
|---|---|---|
| % Shrs Traded | 1.79% | |
| 1yr EPS Est | 0.85 |
| 52-Wk Low | 21.85 | |
|---|---|---|
| 52-Wk High | 37.02 |
|
| Range | 15.17 |
| Prev Close | 26.38 11/4/09 | |
|---|---|---|
| Today's Open | 26.54 | |
| Change | 0.61% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 4.69 M |
| Revenue (LFY) | 194.34 M | |
|---|---|---|
| Earnings (LFY) | 1.95 M | |
| Earnings (MRQ) | 9.37 M | |
| Next Earn Est | 0.223 | |
| Next Earnings | 02/24/2010 |
|
| EPS (TTM) | -0.08 | |
| 1yr EPS Growth | 4,350.00% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | 31.00 | |
| PEG Ratio | 1.03 | |
| Return on Equity | -10.58 | |
| Beta | 0.60 |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
CNBC Video
Onyx Pharmaceuticals' cancer drug could turn out to be a real gem. Working with health care behemoth Bayer, the biotechnology company developed Nexavar, an FDA-approved treatment for advanced kidney cancer ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | 0.223 11/3/09 | — — |
—
—
|
| Last Quarter | 0.223 9/30/09 | 0.28 9/30/09 |
0.057
Beat
|
| 2 Quarters Ago | 0.143 6/30/09 | 0.16 6/30/09 |
0.017
Beat
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 60.22 M | 194.34 M |
| Gross Profit | -8.58 M | 193.01 M |
| Operating Income | 8.69 M | -10.40 M |
| Net Income | 9.37 M | 1.95 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts